Literature DB >> 3860169

Assessment of biotin status: clinical implications.

H Baker.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1985        PMID： 3860169     DOI： 10.1111/j.1749-6632.1985.tb18432.x

Source DB:  PubMed          Journal:  Ann N Y Acad Sci        ISSN： 0077-8923            Impact factor:   5.691


× No keyword cloud information.
  4 in total

1.  Pretargeted radioimmunotherapy using genetically engineered antibody-streptavidin fusion proteins for treatment of non-hodgkin lymphoma.

Authors:  Steven I Park; Jaideep Shenoi; Shani M Frayo; Donald K Hamlin; Yukang Lin; D Scott Wilbur; Patrick S Stayton; Nural Orgun; Mark Hylarides; Franz Buchegger; Aimee L Kenoyer; Amanda Axtman; Ajay K Gopal; Damian J Green; John M Pagel; Oliver W Press
Journal:  Clin Cancer Res       Date:  2011-10-05       Impact factor: 12.531

2.  Design and synthesis of bis-biotin-containing reagents for applications utilizing monoclonal antibody-based pretargeting systems with streptavidin mutants.

Authors:  D Scott Wilbur; Steven I Park; Ming-Kuan Chyan; Feng Wan; Donald K Hamlin; Jaideep Shenoi; Yukang Lin; Shani M Wilbur; Franz Buchegger; Anastasia Pantelias; John M Pagel; Oliver W Press
Journal:  Bioconjug Chem       Date:  2010-07-21       Impact factor: 4.774

3.  Role of human serum biotinidase as biotin-binding protein.

Authors:  J Chauhan; K Dakshinamurti
Journal:  Biochem J       Date:  1988-11-15       Impact factor: 3.857

Review 4.  Cupid and Psyche system for the diagnosis and treatment of advanced cancer.

Authors:  Akira Sugiyama; Takeshi Kawamura; Toshiya Tanaka; Hirofumi Doi; Takefumi Yamashita; Keiko Shinoda; Hideaki Fujitani; Kenzo Yamatsugu; Yohei Shimizu; Toshifumi Tatsumi; Kazuki Takahashi; Motomu Kanai; Eiichi Mizohata; Tatsuya Kawato; Takefumi Doi; Tsuyoshi Inoue; Tatsuhiko Kodama
Journal:  Proc Jpn Acad Ser B Phys Biol Sci       Date:  2019       Impact factor: 3.493
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.